[ad_1]
Officials are confident that the vaccine, which Pfizer is developing with German company BioNTech SE, will be suitable for vaccinating people before Christmas, The Times reports.
The portal tv3.lt has already written that the results of preliminary tests obtained by Pfizer / BioNTech show that the effectiveness of the vaccine they produce reaches 90%.
US drug makers said this week that if the trials are successful, the company expects US regulators to request immediate permission to market the vaccine shortly after sufficient data on the vaccine’s safety is collected in the second half of November.
But hopes of ending the COVID-19 pandemic are fading, with one of the UK’s leading health experts warning that early vaccines may not be safe.
Kate Bingham, head of the UK Vaccine Task Force, has said in the past that there is very little hope of getting the vaccine by Christmas. Now his predictions are even more pessimistic: He thinks the first-generation vaccines now being tested in humans are likely imperfect.
“We need to be prepared in case the vaccines do not prevent infection, but simply relieve symptoms, and so they can be effective for a short time or not for everyone,” Bingham said in a comment to The Lancet.
He added that it is not known at this time if we will have the vaccine and cautioned that many, if not all, of the vaccines we are currently testing could fail.
[ad_2]
